Assessment and Management of Cancer Pain

A review

The lecture duration is 18min.

0.5 CPD Points, 0.5 CEUs, 0.5 CME credits approval pending.
Accredited by CPDUK, CBRN and Provider Pending.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Jeannine Brant
Executive Director of Clinical Science and Innovation at City of Hope, President of the Oncology Nursing Society, Duarte, California
Lecture Summary

Pain is a significant problem in individuals with cancer. Pain occurs in approximately 39.3% after curative treatment; 55.0% during anticancer treatment; and 66.4% in advanced, metastatic, or terminal disease. Moderate to severe pain (numerical rating scale score >/=5) is common and reported by 38.0% of all patients. This demonstrates a significant challenge as unrelieved pain can have a detrimental impact on patient outcomes and quality of life. Opioids are the mainstay of cancer pain management along with co-analgesics such as nonsteroidal anti-inflammatory agents (NSAIDS), anticonvulsants, and serotonin and norepinephrine reuptake inhibitors (SNRIs). Nonpharmacologic modalities are also important to employ and include education, cognitive behavioral therapy, and other important strategies to facilitate coping and overall comfort. This presentation will highlight evidence-based strategies for the assessment and management of pain in patients with cancer.

Target Audience

Oncology nurses
Trainee oncology doctors
General practitioners

Learning Objectives:

Upon completion of this activity, you should be able to:

  • List the best method to assess pain
  • Describe pharmacologic approaches to the management of pain
  • Discuss nonpharmacologic approaches to the management of pain that nurses can do independently

None.